Hyderabad, Jan 3: Expressing delight over the approval on restricted emergency use of its COVID-19 vaccine Covaxin, Bharat Biotech on Sunday said it has generated excellent safety data with robust immune responses to multiple viral proteins that persist and their goal
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2KXhy19
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2KXhy19
ConversionConversion EmoticonEmoticon